Fresenius Medical Care AG

BUL:FME Stock Report

Market Cap: €11.2b

Fresenius Medical Care KGaA Past Earnings Performance

Past criteria checks 1/6

Fresenius Medical Care KGaA's earnings have been declining at an average annual rate of -16.6%, while the Healthcare industry saw earnings growing at 12.6% annually. Revenues have been growing at an average rate of 2% per year. Fresenius Medical Care KGaA's return on equity is 5.8%, and it has net margins of 3.5%.

Key information

-16.6%

Earnings growth rate

-15.4%

EPS growth rate

Healthcare Industry Growth13.4%
Revenue growth rate2.0%
Return on equity5.8%
Net Margin3.5%
Next Earnings Update09 May 2023

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Fresenius Medical Care KGaA makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

BUL:FME Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 2219,3986733,506229
30 Sep 2219,0487633,570234
30 Jun 2218,3938063,311225
31 Mar 2217,9578783,172222
31 Dec 2117,6199693,012221
30 Sep 2117,3729183,011205
30 Jun 2117,3449982,986198
31 Mar 2117,5811,1312,868197
31 Dec 2017,8591,1642,966194
30 Sep 2018,0391,3302,991190
30 Jun 2018,0441,3093,016187
31 Mar 2017,8321,2123,099185
31 Dec 1917,4771,2002,944168
30 Sep 1917,1961,2822,967138
30 Jun 1916,8351,2342,978122
31 Mar 1916,7041,9742,898111
31 Dec 1816,5471,9822,857114
30 Sep 1816,6761,9513,126131
30 Jun 1816,9541,9753,185133
31 Mar 1817,2111,2503,374130
31 Dec 1717,7841,2803,640111
30 Sep 1717,7711,2493,417134
30 Jun 1717,6471,2443,407145
31 Mar 1717,2011,2393,262144
31 Dec 1616,5701,1443,133147
30 Sep 1616,1011,0633,047143
30 Jun 1615,8419983,027136
31 Mar 1615,4029332,961130

Quality Earnings: FME has high quality earnings.

Growing Profit Margin: FME's current net profit margins (3.5%) are lower than last year (5.5%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: FME's earnings have declined by 16.6% per year over the past 5 years.

Accelerating Growth: FME's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: FME had negative earnings growth (-30.5%) over the past year, making it difficult to compare to the Healthcare industry average (-5.3%).


Return on Equity

High ROE: FME's Return on Equity (5.8%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.